Showing 5851-5860 of 6035 results for "".
- Regenxbio Completes Dosing of Fourth Cohort in Phase 1 Trial of RGX-314 Gene Therapy for Wet AMDhttps://modernod.com/news/regenxbio-completes-dosing-of-fourth-cohort-in-phase-1-trial-of-rgx-314-gene-therapy-for-wet-amd/2479815/Regenxbio announced it has completed dosing of the fourth cohort of six patients in a phase 1 clinical trial evaluating RGX-314 for the treatment of wet age-related macular degeneration (AMD). A total of 24 subjects have been dosed in the trial. The company also announced that an updated summary
- Ophthotech Completes Patient Recruitment for Its Phase 2b Clinical Trial of Zimura for Geographic Atrophy Secondary to Dry AMDhttps://modernod.com/news/ophthotech-completes-patient-recruitment-for-its-phase-2b-clinical-trial-of-zimura-for-geographic-atrophy-secondary-to-dry-amd/2479816/Ophthotech announced completion of patient recruitment for its phase 2b clinical trial of Zimura (avacincaptad pegol), the company’s complement factor C5 inhibitor, monotherapy in patients with geographic atrophy secondary to dry age-related macular degeneration (AMD). Complement factor C5
- The Refractive Surgery Council Rolls Out New “RSC Verified” Patient Education Program for Surgeonshttps://modernod.com/news/the-refractive-surgery-council-rolls-out-new-rsc-verified-patient-education-program-for-surgeons/2479820/Refractive surgeons who want to play a leading role in patient education and signal their commitment to quality now have a new resource: The RSC Verified program, according to The Refractive Surgery Council (RSC). The program, introduced by the RSC, opens the council’s vast library o
- Alcon Introduces Enhanced WaveLight Refractive Suitehttps://modernod.com/news/alcon-introduces-enhanced-wavelight-refractive-suite/2479821/Alcon unveiled software and hardware enhancements to the WaveLight Refractive Suite designed to provide surgeons and patients a more comfortable and efficient LASIK experience. The new platform offers a modernized user interface, ergonomic design, and expanded equipment color options. “Al
- Eyenuk Expands into Germany with Launch of EyeArt Artificial Intelligence Eye Screening for Diabetic Retinopathyhttps://modernod.com/news/eyenuk-expands-into-germany-with-launch-of-eyeart-artificial-intelligence-eye-screening-for-diabetic-retinopathy/2479826/Eyenuk announced its expansion into Germany with the adoption of EyeArt artificial intelligence (AI) technology for the screening of diabetic retinopathy at Diabetes Center Mergentheim in Bad Mergentheim, Germany. The center is the first dedicated diabetic clinic in Germany to use artificial inte
- First FDA-Approved Iris Prosthesis Now Available in the United Stateshttps://modernod.com/news/veo-ophthalmics-launches-customflex-artificialiris-in-the-united-states/2479835/VEO Ophthalmics announced the launch of the ‘Customflex ArtificialIris,’ the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from cong
- Compulink Showcases Eyecare Specific Artificial Intelligence EHR Solution at Vision Expo West 2018https://modernod.com/news/compulink-showcases-eyecare-specific-artificial-intelligence-ehr-solution-at-vision-expo-west-2018/2479838/Compulink Healthcare Solutions will demonstrate the latest enhancements to Eyecare Advantage at this week’s International Vision Expo West. This includes new artificial intelligence (AI)-enabled features in a release its calling Advantage SMART Practice. Adva
- National Industries for the Blind Announces New Strategic Alliancehttps://modernod.com/news/national-industries-for-the-blind-announces-new-strategic-alliance/2479842/National Industries for the Blind (NIB) announced a new strategic alliance with the William L. Hudson BVI Workforce Innovation Center to deliver world-class training and professional development for people who are blind. The William L. Hudson BVI Workforce Innovation Center, located in
- ASCRS Releases Preliminary CyPass Withdrawal Consensus Statementhttps://modernod.com/news/ascrs-releases-preliminary-cypass-withdrawal-consensus-statement/2479843/The American Society of Cataract and Refractive Surgery convened a CyPass Withdrawal Task Force to review the data from the COMPASS-XT study and related research and develop an independent physician guidance document associated with the voluntary withdrawal of Alcon’s CyPass Micro-Stent. To
- Bayer, Novartis Lose Case Seeking to End NHS Use of Avastin in Wet AMDhttps://modernod.com/news/bayer-novartis-lose-case-seeking-to-end-nhs-use-of-avastin-in-wet-amd/2479853/The UK High Court on Friday ruled that 12 NHS bodies in the north-east of England can continue to use Roche’s Avastin (bevacizumab) for the treatment of wet age-related macular degeneration (AMD) after dismissing a challenge by Bayer and Novartis. In the case, Bayer and Novartis, which mark